Warsaw, Poland

Violetta Cecuda-Adamczewska



Average Co-Inventor Count = 16.8

ph-index = 1


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Violetta Cecuda-Adamczewska: Innovator in Influenza Research

Introduction

Violetta Cecuda-Adamczewska is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and vaccine antigens against influenza viruses. With a total of three patents to her name, her work has broad implications for immunoprophylaxis and immunotherapy.

Latest Patents

Her latest patents include innovative solutions such as monoclonal antibodies against hemagglutinin of H5-serotype influenza viruses and their uses. These antibodies are selected from a specific group and have applications in both humans and animals. Additionally, she has developed hybridomas that produce these antibodies, along with compositions and diagnostic kits for detecting H5-serotype influenza viruses. Another notable patent involves the use of influenza virus hemagglutinin protein as a vaccine antigen, particularly a fragment of H5 hemagglutinin from the highly pathogenic avian influenza virus H5N1 strain. This protein is intended for use in vaccines administered to chickens, showcasing her commitment to advancing veterinary medicine.

Career Highlights

Violetta has worked with esteemed organizations such as the Institute of Biotechnology and Antibiotics and the Łukasiewicz Research Network—Institute of Biotechnology and Antibiotics. Her career reflects a dedication to research and innovation in the biotechnology sector.

Collaborations

Throughout her career, Violetta has collaborated with notable colleagues, including Piotr Borowicz and Violetta Sączyńska. These partnerships have further enriched her research and contributions to the field.

Conclusion

Violetta Cecuda-Adamczewska stands out as a key figure in the fight against influenza through her innovative research and patents. Her work not only enhances our understanding of viral infections but also paves the way for effective treatments and preventive measures.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…